Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -150.01x as of the fiscal period ended Saturday, December 31, 2022.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-150.01x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-2229.37%
vs the sector median at left
Zentalis Pharmaceuticals, Inc.
Market Cap
$190.07M
Interest Coverage Ratio
-150.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$189.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$192.49M
Interest Coverage Ratio
-1204.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.60M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$198.33M
Interest Coverage Ratio
N/A
TTM Avg
4.80x
3Y Avg
4.80x
5Y Avg
4.80x
Market Cap
$180.47M
Interest Coverage Ratio
-709.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$179.75M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | $190.07M | -150.01x | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | N/A | N/A | N/A | N/A |
| RxSight, Inc. (RXST)vs › | $192.49M | -1204.75x | N/A | N/A | N/A |
| Surrozen, Inc. (SRZN)vs › | $197.18M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | N/A | N/A | N/A | N/A |
| Exagen Inc. (XGN)vs › | $197.87M | -3.26x | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | N/A | 4.80x | 4.80x | 4.80x |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | -709.33x | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | N/A | 14.48x | 14.48x | 14.48x |
Interest Coverage
-150.0x
Debt/Equity
0.26
Current Ratio
4.82
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-12-31 | -150.01x |
